The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
I think there'll be rare cases where, let's say, the drug looks like it'll be effective, but it needs to get into the brain, where a tweak will have to be made, where a different dose or a formulation will be needed. And I think there'll probably be rare cases where probably a company will be needed to be spun out to do it.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.